Bartter’s, Gitelman’s, and Gordon’s Syndromes

Abstract

The molecular basis of many of the inherited disorders of potassium homeostasis has become much clearer in the last two decades. Despite these new insights into the physiology of renal potassium handling, a number of questions remain to be answered. The examples we use to illustrate these issues are Gordon’s syndrome, Bartter’s syndrome, and Gitelman’s syndrome. Our objective is to integrate these new insights into an understanding of the pathophysiology of renal potassium handling. We also propose different ways to think about some of the unresolved issues in this area.

Journal

Journal ID (publisher-id): NEF

Journal ID (nlm-ta): Nephron

Journal ID (doi): 10.1159/issn.1660-8151

Title: Nephron

Publisher: S. Karger AG

ISBN: 978-3-8055-7488-4

ISBN: 978-3-318-00906-4

ISSN (Print): 1660-8151

ISSN (Electronic): 2235-3186

Publication date Subscription-year: 2002

Publication date (Print): October 2002

Publication date (Electronic): 18 October 2002

Volume: 92

Issue: Suppl 1

Pages: 18-27

Affiliations

^aRenal Division, St. Michael’s Hospital, University of Toronto, Toronto, Ont., Canada; ^bDepartment of Medicine, State University of New York, Health Science Center at Brooklyn, N.Y., USA

Article

Publisher ID: 65373 Other ID: Nephron 2002;92(suppl 1):18–27

DOI: 10.1159/000065373

PubMed ID: 12401934

Copyright statement: © 2002 S. Karger AG, Basel

License:

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Page count

Figures: 6, Tables: 1, References: 50, Pages: 10

Product

Self URI (application/pdf): https://www.karger.com/Article/Pdf/65373

Self URI (text/html): https://www.karger.com/Article/FullText/65373

Self URI (journal page): https://www.karger.com/SubjectArea/Nephrology

Categories

Subject: Paper